Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

28 May 2010 07:00

RNS Number : 6940M
ViaLogy PLC
28 May 2010
 



VIALOGY BUSINESS UPDATE 

Analysis delivered for seven new oil well locations 

Company chosen for US DOD security contract  

 

Pasadena, May 28, 2010. ViaLogy (LSE: VIY) ViaLogy announces the recent contractual completion and delivery of analysis for seven new well locations on two onshore projects in Texas and New Mexico. ViaLogy has also completed survey design and acquisition of 3D seismic data for two client leases; drilling locations determined by ViaLogy's proprietary QuantumRD technology will be delivered in July. Depending on customer decisions to commence drilling, ViaLogy expects three clients to drill three to five wells at ViaLogy locations before the end of autumn.

Under contract to a private Oklahoma independent exploration and production firm, ViaLogy has delivered four well locations and supporting analysis. Recommended total depths range from 11,000 to 12,000 feet total depth, and target the Pennsylvanian Morrow channel sandstone at a New Mexico prospect. QuantumRD analysis produced different drilling locations than the client's internal formation structural and porosity models and, significantly, also explained previously drilled dry-holes. To date, only a small number of successful completions have been achieved in this prospect formation. ViaLogy's collaboration with this well-known Oklahoma firm provides another opportunity to demonstrate QuantumRD's value beyond currently used conventional techniques. The timing of the drilling schedule on the ViaLogy recommended locations is under the client's sole control.

Under a new, second contract to analyze a 15 square mile prospect for a Midland, Texas E&P firm, ViaLogy also recently delivered 3 additional well locations targeting both Strawn and Wolfberry carbonate zones. The recommended wells would be drilled to a total depth of 12,000 to12,500 feet. As usual, the client will drill wells per their own operational schedule. The same client presented results and completion data for its first successful ViaLogy well drilled on the prospect three months ago. The presentation was to the Annual Symposium of the Permian Geophysical Society meeting in Midland on May 6, 2010, abstracts on which can be found here: http://pbgs.seg.org/abstracts/index.html 

ViaLogy also supervised subcontractors who completed back-to-back 3D seismic acquisition surveys for ViaLogy clients at two Central Texas prospects - Rocking Chair Ranch for the Buckingham Group and Eubanks Platform for the Enrich Corporation. Both are turnkey contracts with ViaLogy responsible for 3D survey design, acquisition, seismic processing and drilling location recommendations. ViaLogy is receiving services fees as well as a working interest in completed wells on these two fields. ViaLogy's deliverables are due at the end of July. Drilling is expected at some of these locations before the end of the year.

Two previously completed Texas wells in which ViaLogy has a contractual working interest are to be reworked by the operator, Atascosa, to increase production using typical stimulation procedures. One well requires new pumping equipment and tubing, and the other requires a cement "squeeze" into the formation below productive sandstone zones to control water flooding. Such rework is common practice. Production from estimated reserves (publicly available monthly) has been irregular due to operator's decision to periodically shutdown well to avoid formation damage prior to rework. As in all such cases, rework schedule and drilling decisions are solely those of ViaLogy's clients, and out of ViaLogy's control.

Atascosa recently drilled one of the ViaLogy-determined locations in the Escondido formation in south Texas. Borehole logging data showed ViaLogy QuantumRD predictions of porosity and depth estimates of productive sands to be correct, further validating the technology. But post-drilling analysis also suggested a drift in the drilling of the borehole by as much as 200 feet away from the ViaLogy specified endpoint. Atascosa says that had it attempted a controlled directional borehole using "measure while drilling" techniques - as opposed to trying to hit the target with a vertical borehole - the result would have been the good net-pay well predicted by ViaLogy. It will proceed to drill another ViaLogy-recommended location in the same Escondido formation.

ViaLogy CEO Robert Dean commented, "As a services company, ViaLogy provides its best, and we believe unique, advice to our clients who make their own independent drilling and rework business decisions. With respect to our QuantumRD technology, this first Escondido well demonstrates again the technology's value in predicting porosity and locating hydrocarbon reservoirs -- which is what we were asked to do. ViaLogy's focus is now squarely on achieving industry best practice status for the standard and extended use of QuantumRD technology in the oilpatch."

Security and Surveillance

In its security and surveillance business area, ViaLogy announces its first task order contract as a team mate of US defence contractor, Science Applications International Corporation ("SAIC"), on the US Department of Defence Force Protection System II contract. 

On the task order contract, ViaLogy has begun work to develop and test a new software package to validate communications between sensors and other networked security devices. This software will become the validation reference for future security upgrades to US Air Force bases worldwide. Developed by a multi-agency standards body, this new interface standard will serve as the future basis for integrating physical security sensors on large military installations. 

CEO Dean commented further, "ViaLogy has accomplished a lot in the last six months. QuantumRD is gaining acceptance among a diverse client set; we are achieving repeat business; and the technology is being applied to an increasing variety of formations. As we provide more drilling locations to clients, we believe we can achieve a 'drilling queue' that results in regularised drilling activity. On a number of the jobs we've done we are able to indicate not just correct drilling locations, but also why previous drilling efforts have resulted in dry holes-business losses that might have been avoided had QuantumRD been applied. We have our sights set on winning contracts in shale gas and offshore applications, and with a number of key reference customers. Business operations are being managed to budget, and we are on plan with respect to fiscal year revenue goals. At the same time, we face resource constraints that prevent us from moving as aggressively as we would like. We are a new company in the oilpatch with a new technology, and winning commercial acceptance in such a highly specialised and experienced business community needs to be earned. I believe we are well on our way."

Enquiries: 

ViaLogy PLC

Robert W Dean, President & CEO - US +1 626-296-6337

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy / Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner / Jeremy Stephenson, Corporate Broking +44 (0) 20-7107-8000

 

About ViaLogy: Network Centric Signal Processing

ViaLogy is a leading innovator of network-centric, real-time signal processing platforms for sensor applications. ViaLogy is currently deploying and designing computational systems, powered by its patented technologies, for applications in public safety and security, surveillance, defence and geoseismology. ViaLogy focuses on market driven problems where automation, timeliness, quality and reliability of information processing are essential. ViaLogy's core competency incorporates rapidly and accurately detecting weak signals buried in high noise background and clutter. This technology can be employed to solve problems involving sensor integration and information overload challenges involving video, telephony and control sensors, as well as for enhancement of numerous signal processing applications. 

For more information, visit our website at www.ViaLogy.com

About SAIC

Founded by J. Robert Beyster, Ph.D., and a small group of scientists in 1969, Science Applications International Corporation (SAIC), is a FORTUNE 500® scientific, engineering, and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the United States of America and the world, in national security, energy and the environment, critical infrastructure, and health. SAIC and its subsidiaries have approximately 45,000 employees worldwide. 

Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUCWAUPUGRM
Date   Source Headline
14th Dec 20217:00 amRNSHalf-year Report
6th Dec 20217:00 amRNSNotice of Half-year results
18th Nov 20217:00 amRNSDPYD screening recommended in Spain
28th Oct 20217:00 amRNSRanger® Technology to be presented at Labroots
26th Oct 20217:00 amRNSHalf-year Trading update
29th Sep 20217:00 amRNSResult of AGM
28th Sep 20213:00 pmRNSAGM update
28th Sep 20217:00 amRNSAGM Statement
15th Sep 20217:00 amRNSShare option awards
1st Sep 20217:00 amRNSISO 15189:2012 accreditation received
1st Sep 20217:00 amRNSNotice of AGM and Annual Report 2021
19th Aug 202112:04 pmRNSCOVID-19 Surge testing contract
11th Aug 20217:01 amRNSEarn-out Milestone, Issue of Equity & TVR
11th Aug 20217:00 amRNSAudited Final results&unaudited Q1 business update
6th Aug 20217:00 amRNSConfirmation of Results Date
23rd Jul 20217:00 amRNSNotice of Results
1st Jul 202111:09 amRNSHolding(s) in Company
21st Jun 20217:00 amRNSSecond Strategic Partner for Coastal Genomics
18th Jun 20217:00 amRNSContract Award: DPYD testing kits for NHS Wales
17th Jun 20214:32 pmRNSExercise of Options
9th Jun 20217:00 amRNSMulti-year licence and supply agreement
21st May 20214:30 pmRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSDistribution Partnership
18th May 20217:00 amRNSLaunch of IONA Care NIPT service offering
17th May 20217:00 amRNSFurther testing service agreement for MHC
29th Apr 20217:00 amRNSFull year Trading update
26th Apr 20217:00 amRNSFurther National Microbiology Framework awards
19th Apr 20211:21 pmRNSFurther National Microbiology Framework contract
19th Apr 20217:00 amRNSNational Framework contract award
12th Apr 20217:00 amRNSEarn-out Milestone, Issue of Equity & TVR
6th Apr 20212:43 pmRNSTesting service agreement with MyHealthCheckedplc
6th Apr 20211:54 pmRNSAgreement with Boots for COVID-19 sample kits
29th Mar 20214:00 pmRNSCOVID-19 update
23rd Mar 20217:00 amRNSShare option exercises and awards
19th Mar 20217:00 amRNSTwin Pregnancy study published using IONA® Test
17th Mar 20217:00 amRNSAppointment of VP of Sales North America
11th Mar 20217:00 amRNSYourgene Genomic Services portfolio expansion
1st Mar 20217:00 amRNSFirst US Supply Agreement
22nd Feb 20217:00 amRNSPartnership with NPH
10th Feb 202110:51 amRNSCorrection: Director / PDMR Shareholding
10th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSTrading update
13th Jan 20217:00 amRNSDPYD screening recommended in Belgium
11th Jan 20217:00 amRNSClarigene® SARS-CoV-2 Product Update
8th Jan 20217:00 amRNSIssue of Share Options
24th Dec 20207:00 amRNSCOVID-19 update
17th Dec 20207:00 amRNSHalf-year Report
15th Dec 20207:00 amRNSNotice of Half-year Results
2nd Dec 20207:00 amRNSDPYD kits recommended by NHS England
2nd Dec 20207:00 amRNSGenomic testing service launch and Change of name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.